Accelerating time to patients and providers for improved commercial success with Real-World Data
An unnamed pharma/medtech company's commercial team struggled to extract actionable insight from multiple real-world data sources because of data inconsistencies and inflexible providers. Clarivate implemented an agile solution combining comprehensive data with tailored analytics and monthly facility-level deliverables. This let the client's commercial team compare internal sales data against estimated device volumes with confidence, enabling timelier strategies that the page says improved market performance and competitive positioning. No specific percentage or dollar outcome is given on the page.
The customer is anonymised in Clarivate’s own case study — not withheld by us.
Clarivate owns Cortellis, the curated competitive-intelligence and pipeline-tracking platform standard in pharma portfolio-management teams.
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by Clarivate on its own site — read the original case study on clarivate.com ↗
Related use cases
- 01How Bioventus evolved their commercial strategy with real world data and intelligence
- 02Clarivate and CLEO diagnostics are making early detection of ovarian cancer a reality
- 03Making informed investment decisions (Attracting breakthrough innovations from academic research) - SPRIND case study
- 04Gedeon Richter — Case study | Clarivate Regulatory Intelligence Tracking Application
- 05Integrating patient centricity into the Menarini mature brand strategy for commercial excellence
- 06Artificial Intelligence in Pharmacovigilance: Using AI to help GSK detect ICSRs in scientific literature